In summary, the results from the present study indicate that inhibition of the ATX/LPA5 axis in endotoxemia inhibits neuroinflammation in vitro (BV-2 cells) and in vivo (C57Bl/6 endotoxemia model). The gene discussed is ENPP2; the disease is serum lipopolysaccharide activity.